Literature DB >> 32092435

Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors.

Frederic W Hopf1.   

Abstract

The neuropeptide hypocretin/orexin plays a broad and important role in physiological functions ranging from addiction, stress, and anxiety to sleep, energy metabolism, and homeostatic regulation. A number of recent reviews addressing the importance of orexin for different addictive behaviors, especially the contribution of orexin-1-receptors (Ox1Rs) in responding for intoxicants in higher-motivation individuals and situations, and orexin-2-receptor (Ox2Rs) in stress-related aspects of addictive responding. This may parallel the importance of more lateral orexin neurons in the hypothalamus for reward and more medial for stress and arousal. However, there is clearly also some crossover, which may reflect, in part, where positive and negative conditioning (reward- and relief-seeking) are both present concurrently in established addiction, and also where orexin signaling can differ in subregions of a particular brain region. Here, we attempt to examine and synthesize some of the most recent work addressing orexin functions in addiction, including a particular role for Ox1Rs for driving responding in higher-motivation individuals and under higher levels of effort. While there are some commonalities across addictive substances addressed here (alcohol, cocaine, opiates), there are also some differences, which may relate to several factors including the speed of intoxication with a given substance. Together, recent findings have shed important insight and clues into what a more unified role of Ox1Rs might entail, and critical areas for future work. In addition, these many studies support the development of Ox1R blockers for use in humans to counteract addiction and other disorders of motivation. This article is part of the special issue on Neuropeptides.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Anxiety; Orexin; Therapy

Mesh:

Substances:

Year:  2020        PMID: 32092435     DOI: 10.1016/j.neuropharm.2020.108013

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Chemogenetic Inactivation of Orbitofrontal Cortex Decreases Cue-induced Reinstatement of Ethanol and Sucrose Seeking in Male and Female Wistar Rats.

Authors:  John S Hernandez; Annalise N Binette; Taryn Rahman; Jeffrey D Tarantino; David E Moorman
Journal:  Alcohol Clin Exp Res       Date:  2020-07-26       Impact factor: 3.455

2.  Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine.

Authors:  Caroline B Pantazis; Morgan H James; Shayna O'Connor; Noah Shin; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2021-10-11       Impact factor: 7.853

Review 3.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

Review 4.  Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.

Authors:  Jacqueline B Mehr; Deborah Mitchison; Hannah E Bowrey; Morgan H James
Journal:  Neuropsychopharmacology       Date:  2021-06-18       Impact factor: 7.853

Review 5.  Circuit selectivity in drug versus natural reward seeking behaviors.

Authors:  Rusty W Nall; Jasper A Heinsbroek; Todd B Nentwig; Peter W Kalivas; Ana-Clara Bobadilla
Journal:  J Neurochem       Date:  2021-02-13       Impact factor: 5.546

6.  Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats.

Authors:  Vincent N Marty; Mehdi Farokhnia; Joseph J Munier; Yatendra Mulpuri; Lorenzo Leggio; Igor Spigelman
Journal:  Front Neurosci       Date:  2020-12-23       Impact factor: 4.677

7.  Differential importance of nucleus accumbens Ox1Rs and AMPARs for female and male mouse binge alcohol drinking.

Authors:  Claudina Kwok; Kelly Lei; Vincent Pedrozo; Lexy Anderson; Shahbaj Ghotra; Margaret Walsh; Laura Li; JiHwan Yu; Frederic Woodward Hopf
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

Review 8.  Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions.

Authors:  Alain Couvineau; Thierry Voisin; Pascal Nicole; Valerie Gratio; Anne Blais
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

9.  Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine.

Authors:  Jeffrey L Barr; Pingwei Zhao; G Cristina Brailoiu; Eugen Brailoiu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

10.  Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β-Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders.

Authors:  Carolina L Haass-Koffler; Roberta Perciballi; Zoe E Brown; Mary R Lee; William H Zywiak; Jonathan Kurtis; Robert M Swift; Lorenzo Leggio
Journal:  Am J Addict       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.